Core Scientific (CORZ) Accumulated Expenses (2020 - 2026)

Core Scientific has disclosed Accumulated Expenses across 7 years of filings, most recently posting $509.2 million for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 181.88% year-over-year to $509.2 million; the TTM figure through Jun 2026 stood at $509.2 million (up 181.88% YoY), while the FY2025 annual figure was $512.0 million, up 691.65% from the prior year.
• Accumulated Expenses came in at $509.2 million for Q2 2026 at Core Scientific, up from $364.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $512.0 million in Q4 2025 to a low of $18.0 million in Q4 2022.
• Average Accumulated Expenses over 5 years is $158.6 million, with a median of $84.1 million recorded in 2022.
• The largest YoY upside for Accumulated Expenses was 10417.75% in 2022 against a maximum downside of 73.55% in 2022.
• Over 5 years, Accumulated Expenses stood at $18.0 million in 2022, then soared by 900.65% to $179.6 million in 2023, then slumped by 64.0% to $64.7 million in 2024, then soared by 691.65% to $512.0 million in 2025, then slipped by 0.54% to $509.2 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $509.2 million in Q2 2026, $364.5 million in Q1 2026, and $512.0 million in Q4 2025.